| Literature DB >> 36238532 |
Abdulbaqi Al-Toma1, Dorien M Oude Hergelink2, Jacco Tenthof van Noorden1, Jan Jacob Koornstra2.
Abstract
Background and study aims A significant percentage of colonoscopies remain incomplete because of failure to intubate the cecum. The motorized spiral enteroscope (MSE) technique, originally developed for deep small bowel enteroscopy, may be an effective alternative technique in cases of incomplete examination of abnormally long colons (dolichocolon). We prospectively evaluated the success rate of cecal intubation, safety and the therapeutic consequences of using MSE after incomplete conventional colonoscopy. Patients and methods A total of 36 consecutive patients with an indication for diagnostic and/or therapeutic colonoscopy were prospectively enrolled in this multicenter trial. All patients had undergone at least one incomplete colonoscopy attributed to abnormally long colons. Patients with incomplete colonoscopy due to stenosis were excluded. Results Twenty-two men and 14 women (median age 66 years, range 35-82) were enrolled. Median procedure time was 30 minutes (range 16-50). Cecal intubation rate was 100 % and median cecal intubation time was 10 minutes (range 4-30). Abnormalities, mostly neoplastic lesions, were detected in 23 of 36 patients, corresponding to a diagnostic yield of 64 %. All these findings were in the right side of the colon and had not been described by the antecedent incomplete coloscopy. No adverse events occurred. Conclusions In case of a difficult and long colon, MSE is safe and effective for diagnostic and therapeutic colonoscopy. It may provide an attractive solution to accomplish completeness of previous incomplete colonoscopies in these patients. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/).Entities:
Year: 2022 PMID: 36238532 PMCID: PMC9552671 DOI: 10.1055/a-1869-2541
Source DB: PubMed Journal: Endosc Int Open ISSN: 2196-9736
Inclusion and exclusion criteria.
| Inclusion criteria |
Screening for familial colorectal neoplasia Surveillance after previous colorectal neoplasia Positive result of colorectal cancer screening tests Previously identified colorectal polyps with an indication for endoscopic therapy Suspected lower gastrointestinal bleeding Analysis of iron deficiency anemia Chronic diarrhea Abdominal pain with/without change in bowel habit |
| Exclusion criteria | Known pregnancy Poor health status (ASA classification ≥ 4) Contraindication for propofol sedation Known uncorrectable coagulopathy Clinical suspicion of severe inflammatory bowel disease or suspected bowel obstruction Known colonic stenosis |
ASA, American Society of Anesthesiologists.
Patient characteristics.
| Patients | n = 36 |
Men 22 | |
Women 14 | |
| Age, median (range), years | 66 (35–82) |
| ASA* classification | ASA 1 [3 (8.3 %)] |
| ASA 2 [30 (83.3 %)] | |
| ASA 3 [3 (8.3 %)] | |
| Indications for colonoscopy | Surveillance after previous adenoma (n = 19) |
| Iron-deficiency anemia (n = 3) | |
| Surveillance after previous colorectal cancer (n = 3) | |
| Surveillance familial risk colorectal cancer (n = 2) | |
| Screening positive iFOBT (n = 2) | |
| Unexpected findings on radiology (n = 2) | |
| Chronic Diarrhea (n = 2) | |
| Abdominal pain with or without change in bowel habit (n = 3) |
ASA, American Society of Anesthesiologists; iFOBT, immunocemical fecal occult blood test
Procedural data from the 36 patients.
|
|
|
Technical success rate (cecal intubation rate) | 36 (100 %) |
Cecal intubation time, median (range), minutes | 10 (4–30) |
Withdrawal time, median (range), minutes |
12 (6–40)
|
Total procedure time, median (range), minutes |
30 (16–50)
|
|
|
|
Adenoma(s) | 17 (47.2 %) |
Colon cancer | 2 (5.5 %) |
Angiodysplasia(s) | 3 (8.3 %) |
Inflammatory changes (ulcers and erosions) | 1 (2.7 %) |
|
|
|
Polypectomy/endoscopic mucosal resection | 17 (47.2 %) |
Argon plasma coagulation | 3 (8.3 %) |
Others (ink tattoo) | 2 (5.5 %) |
|
|
|
Asymptomatic mild superficial mucosal lesions | 3 (8.3 %) |
Severe adverse events | 0 |
Including time needed for intervention.
Fig. 1 Motorized spiral enteroscopy may facilitate polypectomy of adenomas or serrated lesions in previously inaccessible regions of the colon. That includes a optimal evaluation of lesions using white light and b barrow band Imaging (NBI); c performing submucosal injections and then d resection.